Your browser doesn't support javascript.
loading
[Ablative therapy in kidney cancer: Oncological, functional, perioperative outcomes and cost]. / Thérapies ablatives dans le cancer du rein : résultats oncologiques, périopératoires, fonctionnels et médico-économiques.
Mouracade, P; Tricard, T; Gangi, A; Cathelineau, X; Lang, H.
Afiliação
  • Mouracade P; Service de chirurgie urologique, CHU de Strasbourg, 67000 Strasbourg, France.
  • Tricard T; Service de chirurgie urologique, CHU de Strasbourg, 67000 Strasbourg, France. Electronic address: thibault.tricard@chru-strasbourg.fr.
  • Gangi A; Service d'imagerie interventionnelle, CHU de Strasbourg, 67000 Strasbourg, France.
  • Cathelineau X; Département d'urologie, institut Montsouris, 75014 Paris, France; Université Paris-Descartes, 75006 Paris, France.
  • Lang H; Service de chirurgie urologique, CHU de Strasbourg, 67000 Strasbourg, France.
Prog Urol ; 27(15): 952-970, 2017 Nov.
Article em Fr | MEDLINE | ID: mdl-28890005
ABSTRACT

INTRODUCTION:

The incidence of kidney cancer has increased significantly over the past few decades presumably due to the increased use of imaging. The aim of this article is to describe contemporary outcomes of ablative therapy and to compare them to other therapeutic options in terms of oncological, functional, perioperative outcomes and cost. MATERIAL AND

METHODS:

We searched MEDLINE®, Embase®, using (MeSH) words; from January 2005 through May 2017, and we looked for all the studies. Investigators graded the strength of evidence in terms of methodology, language and relevance.

RESULTS:

Ninety-one articles were analyzed. We described the outcomes of ablative therapy in relation to the energy used and the approach, and compared these outcomes to the other therapeutic options in terms of oncological, functional and perioperative outcomes. We analyzed these studies in order to search for predictive factors influencing the results of ablative therapy. We also analyzed the economic burden of small renal tumor management.

CONCLUSION:

The strength of evidence is based almost entirely on retrospective studies and is susceptible to the inherent limitations of this study design. Although, the evidence was low among studies, our revue showed that, in elderly patients treated with ablative therapy for cT1a tumors, the cancer-specific survival was comparable to partial nephrectomy with differences in overall survival that are explained by competing risks of death in the old population. Considering the functional results, the renal function preservation seems to be comparable between the 2 groups while the perioperative morbidity is higher in the partial nephrectomy group. The evidence base medicine at this time cannot support the extension of the indications of ablative therapy beyond the actual implementations.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Técnicas de Ablação / Neoplasias Renais Idioma: Fr Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Técnicas de Ablação / Neoplasias Renais Idioma: Fr Ano de publicação: 2017 Tipo de documento: Article